Search
Find a recruiting study
7,120 recruiting studies with US sites, from the official ClinicalTrials.gov registry (refreshed Oct 26, 2026). No sign-up needed.
Most recently updated studies · page 87 of 297
- RecruitingPhase 2
Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
XyloCor Therapeutics, Inc.
- Location
- Birmingham, AL + 12 other US sites
- Eligibility basics
- Ages 18–85
- Recruiting
Post Market Clinical Study to Evaluate the Performance of the Versius Surgical System
CMR Surgical Ltd
- Location
- Los Angeles, CA + 1 other US site
- Eligibility basics
- Ages 22+
- RecruitingPhase 1/Phase 2
A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults
35Pharma Inc
- Location
- Tampa, FL + 1 other US site
- Eligibility basics
- Ages 18+
- Recruiting
GAINS Expert Guiding Technology to Coach Life Skill Teaching
Guiding Technologies Corporation
- Location
- Fayetteville, AR
- Eligibility basics
- Ages 3–10
- Recruiting
Tensi+ for Treating Overactive Bladder
Stimuli Technology
- Location
- Beverly Hills, CA + 1 other US site
- Eligibility basics
- Ages 22+
- RecruitingPhase 2
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Novo Nordisk A/S
- Location
- Lancaster, CA + 19 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
Vertex Pharmaceuticals Incorporated
- Location
- Mission Hills, CA + 14 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Novo Nordisk A/S
- Location
- San Diego, CA + 14 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Evaluate MAR002 for Acromegaly
Marea Therapeutics
- Location
- Phoenix, AZ + 2 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Clinical Performance of AH Plus Jet® Root Canal Sealers in Single-cone Protocols
Dentsply Sirona Implants and Consumables
- Location
- New York, NY
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis Bronchiectasis
UCB Biopharma SRL
- Location
- Brandon, FL + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
Study of Resmetirom in Children and Adolescents With MASH
Madrigal Pharmaceuticals, Inc.
- Location
- Indianapolis, IN
- Eligibility basics
- Ages 6–17
- RecruitingPhase 2
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
Vima Therapeutics
- Location
- Farmington Hills, MI
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
Pulmovant, Inc.
- Location
- Kissimmee, FL + 2 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Bristol-Myers Squibb
- Location
- Sacramento, CA + 4 other US sites
- Eligibility basics
- Ages 10–17
- Recruiting
Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study
PathMaker Neurosystems Inc.
- Location
- Boston, MA
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
ONL Therapeutics
- Location
- Gilbert, AZ + 55 other US sites
- Eligibility basics
- Ages 55+
- RecruitingPhase 3
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
Cardiol Therapeutics Inc.
- Location
- Phoenix, AZ + 20 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
AstraZeneca
- Location
- San Francisco, CA + 8 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
ADARx Pharmaceuticals, Inc.
- Location
- Litchfield Park, AZ + 14 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Allogene Therapeutics
- Location
- Phoenix, AZ + 15 other US sites
- Eligibility basics
- Ages 18–74
- RecruitingPhase 3
Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
Dompé Farmaceutici S.p.A
- Location
- Los Angeles, CA + 13 other US sites
- Eligibility basics
- Ages 50–80
- RecruitingPhase 3
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
AstraZeneca
- Location
- Colorado Springs, CO + 7 other US sites
- Eligibility basics
- Ages 18–130
- RecruitingPhase 3
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
Pfizer
- Location
- Miami, FL + 4 other US sites
- Eligibility basics
- Ages 12+
Data source: deploy-time snapshot of the ClinicalTrials.gov API. How we list studies